Ameloblastoma is one of the most common benign odontogenic tumors of the jaw that
constitutes about 10% of all tumors that arise in the mandible and maxilla. It is a slow …

Simple Summary Ameloblastoma is a benign odontogenic tumour, and the patient always
presents at a later stage when the tumour is already in an aggressive state. The finding of …

Background The ameloblastoma management is still challenging to the high recurrence
rates and significant morbidity associated with radical treatment. The purpose of this 10-year …

Background: Ameloblastoma is an odontogenic tumor occurring in jaws, with local
aggressiveness and postoperative recurrence. This study was aim to investigate the clinical …

Matricellular proteins (MCPs) are defined as extracellular matrix (ECM) associated proteins
that are important regulators and integrators of microenvironmental signals, contributing to …

Ameloblastoma is a rare odontogenic benign tumor accounting for less than 1% of head and
neck tumors. Advanced next generation sequencing (NGS) analyses identified high …

Head and neck cancer (HNC), a common malignancy worldwide, is associated with high
morbidity and mortality rates. Squamous cell carcinoma is the most common HNC type …

Background Odontogenic tumors (OTs) are considered important among oral lesions
because of their clinicopathological heterogeneity and variable biological behavior. The …

Objectives. Ameloblastoma is a slow‐growing epithelial odontogenic neoplasm of the jaws
with a high recurrence rate. The main treatment strategies for this lesion are radical or …

Objective This article aims to systematically and comprehensively discuss molecular biology-
related progress and targeted therapeutic strategies for ameloblastoma, which are expected …